Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis

Excess mortality after hip fracture among the elderly in Taiwan: A nationwide population-based cohort study

(2013) Chang-Bi Wang et al.   BONE

The association between serious upper gastrointestinal bleeding and incident bisphosphonate use: a population-based nested cohort study

(2013) Jennifer A Knopp-Sihota et al.   BMC Geriatrics

Glutaredoxin2 isoform b (Glrx2b) promotes RANKL-induced osteoclastogenesis through activation of the p38-MAPK signaling pathway

(2012) Jeong-Tae Yeon et al.   BMB Reports

Suppressive Effects of the Leaf of Terminalia catappa L. on Osteoclast Differentiation In Vitro and Bone Weight Loss In Vivo

(2012) Tomoyuki KOYAMA et al.   JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY

Quinoxaline derivative of oleanolic acid inhibits osteoclastic bone resorption and prevents ovariectomy-induced bone loss

(2011) Yu Zhao et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Upstream Stimulatory Factors Regulate OSCAR Gene Expression in RANKL-Mediated Osteoclast Differentiation

(2008) Jung Ha Kim et al.   JOURNAL OF MOLECULAR BIOLOGY

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

(2007) Kabsun Kim et al.   MOLECULAR ENDOCRINOLOGY